Previous studies have shown that the liver IL-6 expression is correlated positively with the severity of inflammation and the degree of fibrosis observed in NASH patients, coupled with the fact that saturated FFA has been demonstrated to induce IL-6 production by hepatocytes in vitro [55]. Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.